Follow
Modest von Korff
Modest von Korff
Scientist, Idorsia Pharmaceuticals Ltd.
Verified email at idorsia.com
Title
Cited by
Cited by
Year
DataWarrior: an open-source program for chemistry aware data visualization and analysis
T Sander, J Freyss, M Von Korff, C Rufener
Journal of chemical information and modeling 55 (2), 460-473, 2015
14022015
OSIRIS, an entirely in-house developed drug discovery informatics system
T Sander, J Freyss, M von Korff, JR Reich, C Rufener
Journal of chemical information and modeling 49 (2), 232-246, 2009
2452009
A systematic evaluation of the benefits and hazards of variable selection in latent variable regression. Part I. Search algorithm, theory and simulations
K Baumann, H Albert, M Von Korff
Journal of Chemometrics: A Journal of the Chemometrics Society 16 (7), 339-350, 2002
1172002
Comparison of ligand-and structure-based virtual screening on the DUD data set
M von Korff, J Freyss, T Sander
Journal of chemical information and modeling 49 (2), 209-231, 2009
1072009
Toxicity-indicating structural patterns
M von Korff, T Sander
Journal of chemical information and modeling 46 (2), 536-544, 2006
802006
A systematic evaluation of the benefits and hazards of variable selection in latent variable regression. Part II. Practical applications
K Baumann, M Von Korff, H Albert
Journal of Chemometrics: A Journal of the Chemometrics Society 16 (7), 351-360, 2002
532002
Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility
M von Korff, J Freyss, T Sander
Journal of chemical information and modeling 48 (4), 797-810, 2008
412008
Molecular complexity calculated by fractal dimension
M von Korff, T Sander
Scientific reports 9 (1), 967, 2019
342019
GPCR-tailored pharmacophore pattern recognition of small molecular ligands
M von Korff, M Steger
Journal of chemical information and computer sciences 44 (3), 1137-1147, 2004
292004
Accuracy evaluation and addition of improved dihedral parameters for the MMFF94s
J Wahl, J Freyss, M von Korff, T Sander
Journal of cheminformatics 11 (1), 53, 2019
262019
Stereochemical behaviour of κ-agonistic 2, 4-dipyridin-2-yl-3, 7-diazabicyclo [3.3. 1] nonanones—influence of the substituent in position N 3
U Kuhl, M von Korff, K Baumann, C Burschka, U Holzgrabe
Journal of the Chemical Society, Perkin Transactions 2, 2037-2042, 2001
242001
The screening compound collection: a key asset for drug discovery
C Boss, J Hazemann, T Kimmerlin, M von Korff, U Lüthi, O Peter, T Sander, ...
Chimia 71 (10), 667-667, 2017
222017
Assessing the predictive power of unsupervised visualization techniques to improve the identification of GPCR-focused compound libraries
M von Korff, K Hilpert
Journal of chemical information and modeling 46 (4), 1580-1587, 2006
172006
About complexity and self-similarity of chemical structures in drug discovery
M von Korff, T Sander
Chaos and Complex Systems: Proceedings of the 4th International …, 2012
132012
Limits of prediction for machine learning in drug discovery
M von Korff, T Sander
Frontiers in Pharmacology 13, 832120, 2022
42022
Data mining in MEDLINE for disease-disease associations via second order co-occurrence
M Von Korff, B Deffarges, T Sander
2015 IEEE Symposium Series on Computational Intelligence, 314-321, 2015
32015
Integration of distributed computing into the drug discovery process
M von Korff, C Rufener, M Stritt, J Freyss, R Bär, T Sander
Expert Opinion on Drug Discovery 6 (2), 103-107, 2011
32011
Neue Algorithmen zur Variablenselektion und Variablenwichtung in der Chemometrie
M von Korff
32001
Predictive power of time-series based machine learning models for DMPK Measurements in Drug Discovery
M von Korff, O Corminboeuf, J Gatfield, S Jeay, I Reymond, T Sander
International Conference on Artificial Neural Networks, 741-746, 2019
22019
A new relevance estimator for the compilation and visualization of disease patterns and potential drug targets
M von Korff, T Fink, T Sander
PACIFIC SYMPOSIUM ON BIOCOMPUTING 2017, 312-323, 2017
22017
The system can't perform the operation now. Try again later.
Articles 1–20